Ophthalmic Pharmacology Practice Questions

Q: Which of the following is NOT used topically for ophthalmic use?

Methylprednisolone. **Explanation:** The correct answer is **Methylprednisolone**. **1. Why Methylprednisolone is the correct answer:** In ophthalmology, corticosteroids are used topically to treat non-infectious inflammatory conditions. While Methylprednisolone is a potent intermediate-acting corticosteroid frequently used systemically (IV/Oral) or via **sub-Tenon/intraocular injection**, it is **not available as a topical ophthalmic drop or ointment**. This is primarily due to its poor corneal penetration and the availability of more effective topical alternatives. **2. Why the other options are incorrect:** * **Prednisolone (Option B):** Specifically **Prednisolone Acetate (1%)**, is the "gold standard" topical steroid for intraocular inflammation (uveitis) due to its superior lipophilic properties and excellent corneal penetration. * **Dexamethasone (Option D):** A highly potent long-acting steroid commonly used topically (0.1%) for post-operative inflammation and surface allergies. * **Hydrocortisone (Option A):** A low-potency steroid used topically, primarily for mild ocular surface or eyelid inflammation (e.g., allergic blepharitis), as it has a lower risk of inducing a significant rise in intraocular pressure (IOP). **3. High-Yield Clinical Pearls for NEET-PG:** * **Steroid-Induced Glaucoma:** Topical steroids can increase IOP by decreasing aqueous outflow through the trabecular meshwork. **Dexamethasone** is a high-potency "strong" steroid with a high risk, while **Fluorometholone** and **Loteprednol** are "soft" steroids with a lower risk of IOP spikes. * **Contraindication:** Topical steroids are strictly contraindicated in **Herpetic Dendritic Ulcers** (epithelial keratitis) as they promote viral replication and can lead to geographic ulcers. * **Side Effects:** Long-term topical steroid use is associated with **Posterior Subcapsular Cataracts (PSC)** and secondary glaucoma.

Q: 5% guanethidine is used for which of the following conditions?

Thyrotoxic ophthalmopathy. **Explanation:** **Correct Answer: C. Thyrotoxic ophthalmopathy** **Mechanism and Rationale:** Guanethidine is a sympatholytic agent that acts by depleting norepinephrine from postganglionic sympathetic nerve endings. In **Thyrotoxic ophthalmopathy (Graves' Orbitopathy)**, there is excessive sympathetic stimulation of **Müller’s muscle** (a smooth muscle in the upper eyelid), leading to lid retraction. Topical 5% guanethidine reduces this sympathetic overactivity, effectively lowering the upper eyelid position and improving the cosmetic appearance and corneal exposure associated with lid retraction. **Analysis of Incorrect Options:** * **A. Ptosis:** Guanethidine causes a "chemical ptosis" by relaxing Müller’s muscle. Therefore, it would worsen pre-existing ptosis rather than treat it. * **B. Neuro-paralytic keratitis:** This condition results from trigeminal nerve (CN V) palsy leading to loss of corneal sensation. Treatment focuses on lubrication and tarsorrhaphy, not sympatholytics. * **D. Horner's syndrome:** This condition is characterized by sympathetic denervation (resulting in ptosis and miosis). Guanethidine, being a sympatholytic, would mimic or exacerbate the signs of Horner's syndrome rather than treat it. (Note: Cocaine or Apraclonidine are typically used for the *diagnosis* of Horner's). **High-Yield Clinical Pearls for NEET-PG:** * **Müller’s Muscle:** Supplied by sympathetic fibers; its overaction causes lid retraction (Dalrymple’s sign) in Graves' disease. * **Guanethidine Side Effects:** Long-term topical use can cause superficial punctate keratitis (SPK) and conjunctival fibrosis. * **Other uses:** While historically used for glaucoma (to decrease aqueous production), it is now largely obsolete for that indication due to better alternatives. * **Thyroid Eye Disease:** The most common cause of both unilateral and bilateral proptosis in adults.

Q: Steroids are contraindicated in which of the following conditions?

Fungal corneal ulcer. **Explanation:** The correct answer is **Fungal corneal ulcer**. Topical steroids are strictly contraindicated in active fungal and pyogenic bacterial infections of the cornea. **Why Fungal Corneal Ulcer?** Steroids are potent immunosuppressants. In fungal keratitis, they inhibit the local inflammatory response and leukocyte migration, allowing fungi to proliferate unchecked. Furthermore, steroids can enhance the activity of collagenolytic enzymes, leading to rapid stromal melting and potential corneal perforation. **Analysis of Other Options:** * **Herpes Keratitis:** This is a nuanced area. While steroids are contraindicated in **epithelial** (dendritic) herpes simplex keratitis because they promote viral replication, they are actually the mainstay of treatment for **stromal** herpetic keratitis and disciform keratitis to reduce scarring. Since the option is broad, fungal ulcer remains the more absolute contraindication. * **Atopic Dermatitis:** Steroids are frequently used to manage the inflammatory components of atopic dermatitis and its ocular manifestations (atopic keratoconjunctivitis), provided there is no secondary infection. * **Exposure Keratitis:** The primary treatment is lubrication and protection (tarsorrhaphy). While steroids aren't the first line, they are not strictly contraindicated unless a secondary fungal or viral infection develops. **High-Yield Clinical Pearls for NEET-PG:** * **Steroid-Induced Glaucoma:** Occurs due to increased resistance to aqueous outflow at the trabecular meshwork (associated with the *MYOC* gene). * **Steroid-Induced Cataract:** Typically presents as **Posterior Subcapsular Cataract (PSC)**. * **Rule of Thumb:** Never prescribe steroids in a patient with a "red eye" until a corneal ulcer (specifically fungal or dendritic) has been ruled out via fluorescein staining.

Q: Which of the following drugs can be used topically in the eye?

Tetracyclines. **Explanation:** **Tetracyclines** (Option D) are widely used in ophthalmology as topical preparations (1% ointment). They are effective against a broad spectrum of bacteria and are particularly high-yield for NEET-PG as the drug of choice for **Trachoma** (caused by *Chlamydia trachomatis*). Beyond their antimicrobial properties, topical tetracyclines are used in managing **Meibomian Gland Dysfunction (MGD)** and blepharitis due to their ability to inhibit bacterial lipases and provide anti-inflammatory effects. **Why the other options are incorrect:** * **Erythromycin (A):** While erythromycin ophthalmic ointment exists globally, in the context of standard Indian pharmacopoeia and common clinical practice reflected in exams, it is less frequently used topically compared to Tetracyclines or Macrolides like Azithromycin. * **Ganciclovir (B):** Ganciclovir is an antiviral. While a topical gel formulation exists for Herpetic Keratitis, it is highly specialized. In the context of this specific question set, Tetracycline is the more "classic" topical agent. * **Clindamycin (C):** Clindamycin is primarily used systemically or topically for acne/skin infections. It is **not** used as a standard topical ophthalmic drop or ointment. **High-Yield Clinical Pearls for NEET-PG:** 1. **Trachoma Management:** The WHO "SAFE" strategy uses topical Tetracycline (1% ointment twice daily for 6 weeks) or a single dose of oral Azithromycin. 2. **Ocular Rosacea:** Tetracyclines (Doxycycline) are the systemic drug of choice for ocular rosacea. 3. **Contraindication:** Avoid systemic tetracyclines in children (<8 years) and pregnant women due to bone growth inhibition and tooth discoloration; however, **topical** use does not carry these systemic risks.

Q: Which short-acting mydriatic is used for fundoscopy?

Tropicamide. **Explanation:** **Tropicamide** is the drug of choice for diagnostic fundoscopy because it is the **fastest and shortest-acting** topical antimuscarinic agent. It works by blocking the M3 receptors in the sphincter pupillae muscle, leading to passive mydriasis. * **Why Tropicamide is correct:** It has a rapid onset of action (15–20 minutes) and a short duration of effect (4–6 hours). This allows for a quick clinical examination while ensuring the patient’s vision returns to normal within the same day, minimizing the duration of photophobia and blurred vision. **Analysis of Incorrect Options:** * **Atropine:** The most potent cycloplegic with the longest duration of action (7–10 days). It is never used for routine fundoscopy due to prolonged recovery and risk of systemic toxicity in children. * **Homatropine:** A moderately long-acting agent (duration 2–3 days). It is primarily used in the treatment of anterior uveitis to prevent posterior synechiae and relieve ciliary spasm. * **Cyclopentolate:** Has a duration of 24 hours. While used for cycloplegic refraction in children, its effect lasts too long for routine diagnostic fundoscopy. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Cycloplegic Refraction:** Atropine (children <7 years), Cyclopentolate (7–24 years), Homatropine (adults). * **Phenylephrine:** Often used in combination with Tropicamide to achieve maximal mydriasis (via alpha-1 stimulation of the dilator pupillae) without causing cycloplegia. * **Contraindication:** All mydriatics are contraindicated in patients with a narrow anterior chamber angle due to the risk of precipitating **Acute Angle Closure Glaucoma**.

Q: What is the effect of Epinephrine on aqueous humor dynamics?

Reduces aqueous production and increases outflow facility. ### Explanation Epinephrine (Adrenaline) is a non-selective sympathomimetic that acts on both alpha ($\alpha$) and beta ($\beta$) adrenergic receptors. Its effect on aqueous humor dynamics is unique because it exerts a **biphasic action**: 1. **Reduction of Aqueous Production:** By stimulating $\alpha$-receptors on the ciliary body epithelium, it causes vasoconstriction, which leads to a decrease in the ultrafiltration and active secretion of aqueous humor. 2. **Increase in Outflow Facility:** By stimulating $\beta_2$-receptors in the trabecular meshwork and uveoscleral pathways, it increases the ease with which aqueous humor exits the eye. Therefore, **Option C** is correct as it accounts for this dual mechanism of lowering intraocular pressure (IOP). **Analysis of Incorrect Options:** * **Option A & B:** These are incomplete. Epinephrine does not just reduce production; it simultaneously improves drainage. Furthermore, it *increases* (not reduces) outflow facility. * **Option D:** This is physiologically opposite to the therapeutic goal. Increasing production and reducing outflow would raise IOP, which is the opposite of what epinephrine does in a glaucomatous eye. **High-Yield Clinical Pearls for NEET-PG:** * **Dipivefrine:** A prodrug of epinephrine with better corneal penetration and fewer systemic side effects. * **Mydriasis:** Epinephrine causes pupillary dilation (via $\alpha_1$ receptors on the dilator pupillae). Thus, it is **contraindicated in Angle-Closure Glaucoma** as it can precipitate an acute attack. * **Adrenochrome Deposits:** Chronic use can lead to black, oxidative pigment deposits in the conjunctiva. * **Cystoid Macular Edema (CME):** A classic side effect of epinephrine/dipivefrine in **aphakic** patients.

Q: What is the topically used non-selective alpha-agonist in glaucoma?

Dipivefrine. **Explanation:** **Dipivefrine** is the correct answer because it is a prodrug of **Epinephrine**, which is a **non-selective alpha and beta-adrenergic agonist**. **Mechanism of Action:** Dipivefrine is converted into epinephrine by esterases in the cornea. It lowers intraocular pressure (IOP) through a dual mechanism: 1. **Initial effect:** Increases aqueous outflow through the trabecular meshwork (alpha-1 effect). 2. **Secondary effect:** Decreases aqueous production (alpha-2 effect) and increases uveoscleral outflow. As a prodrug, it is more lipophilic than epinephrine, allowing for better corneal penetration and fewer systemic side effects. **Analysis of Incorrect Options:** * **A. Bimatoprost:** This is a **Prostamide (Prostaglandin analogue)**. It is currently the first-line treatment for glaucoma and works by increasing uveoscleral outflow. * **B. Dorzolamide:** This is a topical **Carbonic Anhydrase Inhibitor (CAI)**. It reduces IOP by decreasing the production of aqueous humor from the ciliary body epithelia. * **C. Brimonidine:** While an alpha-agonist, it is **highly selective for Alpha-2 receptors**. It is not non-selective. It reduces aqueous production and increases uveoscleral outflow. **High-Yield Clinical Pearls for NEET-PG:** * **Adrenochrome deposits:** Epinephrine/Dipivefrine can cause black pigment deposits in the conjunctiva. * **Cystoid Macular Edema (CME):** Epinephrine compounds are contraindicated in **aphakic** patients as they can induce CME. * **Mydriasis:** Unlike Brimonidine, Dipivefrine can cause pupillary dilation; hence, it is contraindicated in angle-closure glaucoma. * **Drug of choice (DOC)** for primary open-angle glaucoma (POAG) is Prostaglandin analogues (e.g., Latanoprost).

Q: Which is the fastest acting cycloplegic drug?

Tropicamide. **Explanation:** The speed of onset of a cycloplegic drug is determined by its pharmacokinetics and its affinity for the muscarinic receptors in the ciliary muscle. **1. Why Tropicamide is correct:** Tropicamide is a synthetic derivative of tropic acid with the **fastest onset of action** among all cycloplegics and mydriatics. It reaches its peak mydriatic effect in 20–40 minutes and peak cycloplegic effect within **20–30 minutes**. Due to its rapid onset and short duration of action (4–6 hours), it is the drug of choice for routine fundus examinations. **2. Analysis of Incorrect Options:** * **Atropine (A):** It is the most potent cycloplegic but has the **slowest onset** (30–60 minutes for peak effect) and the longest duration (7–12 days). It is used primarily for refraction in children under 7 years or in cases of active uveitis. * **Cyclopentolate (C):** It has a rapid onset (25–75 minutes) and is the **drug of choice for cycloplegic refraction** in children and young adults, but it is slower than Tropicamide. * **Homatropine (D):** This is a semi-synthetic alkaloid with an intermediate onset (30–60 minutes) and duration (1–3 days). It is less potent than Atropine and is mainly used in the treatment of anterior uveitis to prevent synechiae. **High-Yield Clinical Pearls for NEET-PG:** * **Fastest Acting:** Tropicamide. * **Most Potent/Longest Acting:** Atropine. * **Drug of Choice (DOC) for Cycloplegic Refraction (Children):** Cyclopentolate. * **DOC for Refraction in Children <7 years/Accommodative Esotropia:** Atropine (Ointment is preferred over drops to prevent systemic toxicity). * **Mechanism:** All these drugs are **parasympatholytics** (Muscarinic antagonists) that block the M3 receptors in the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia).

Question 1

Which of the following is NOT used topically for ophthalmic use?

Accepted Answer

Methylprednisolone

Answer

Hydrocortisone

Answer

Prednisolone

Answer

Dexamethasone

Question 2

5% guanethidine is used for which of the following conditions?

Accepted Answer

Thyrotoxic ophthalmopathy

Answer

Ptosis

Answer

Neuro-paralytic keratitis

Answer

Horner's syndrome

Question 3

Steroids are contraindicated in which of the following conditions?

Accepted Answer

Fungal corneal ulcer

Answer

Herpes keratitis

Answer

Atopic dermatitis

Answer

Exposure keratitis

Question 4

Which of the following drugs can be used topically in the eye?

Accepted Answer

Tetracyclines

Answer

Erythromycin

Answer

Ganciclovir

Answer

Clindamycin

Question 5

Which short-acting mydriatic is used for fundoscopy?

Accepted Answer

Tropicamide

Answer

Atropine

Answer

Homatropine

Answer

Cyclopentolate

Question 6

What is the effect of Epinephrine on aqueous humor dynamics?

Accepted Answer

Reduces aqueous production and increases outflow facility

Answer

Reduces aqueous production

Answer

Reduces outflow facility

Answer

Increases aqueous production and reduces outflow facility

Question 7

Which of the following is a steroid-induced ocular complication?

Accepted Answer

All of the above

Answer

Glaucoma

Answer

Papilledema

Answer

Central retinal vein occlusion

Question 8

What is the topically used non-selective alpha-agonist in glaucoma?

Accepted Answer

Dipivefrine

Answer

Bimatoprost

Answer

Dorzolamide

Answer

Brimonidine

Question 9

Which is the fastest acting cycloplegic drug?

Accepted Answer

Tropicamide

Answer

Atropine

Answer

Cyclopentolate

Answer

Homatropine

Question 10

All of the following are true about antiglaucoma drugs except?

Accepted Answer

Usage of Timolol is unsafe in infants

Answer

PGF2 α analogues increase uveoscleral outflow

Answer

Apraclonidine can lead to lid retraction

Answer

Adrenaline can lead to conjunctival pigmentation

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?